Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndrome is a research paper published in PLoS Genetics (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canadian Institutes of Health Research
Grant: MOP-12205
Natural Science and Engineering Council of Canada
Grant: RGPIN-2017-06128
National Institutes of Health
Grant: R21 GM118962
National Institutes of Health
Grant: R03 NS114616
National Institutes of Health
Grant: 1R56NS123059-01
Pathobiology and Treatment of the UBTF E210K Neuroregression Syndrome
NINDS NIH HHS
Grant: R56 NS123059
Natural Sciences and Engineering Research Council of Canada
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R21GM118962-02
The Role of UBTF in Undiagnosed Neurodevelopmental Disorders
National Institutes of Health
Grant: 1R03NS114616-01A1
Examining Progression of a Neurodegenerative Disorder
FWCI
1.26
Citation Percentile
0.8%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals